TP53 and neoplasm: The dual‐inactivation of TP53 and RB1 initiates epigenetic reprogramming events through upregulation of key regulators such as EZH2 and SOX2, fostering a stem cell‐like epigenetic state that ultimately drives tumor development and progression [12].